BackField Trip Health Overview

Field Trip Health Net Income

Latest net income for FTRP: $-48M, below the Healthcare sector average of $16B.

Get informed when a big investor buys or sells

+ Follow

Quarterly Net Income

-$5.24M
↑ 58.21% YoY

As of Jun 2022

Annual Net Income (TTM)

-$48.09M
↓ 47.12% YoY

Trailing 12 months ending Jun 2022

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...

Field Trip Health (FTRP) FAQ

Field Trip Health (FTRP) currently reports a net income of $-48M as of June 2022. That compares with $-33M in the prior-year period — down 47.1% year over year. That is below the Healthcare sector average of $16B. Use the charts on this page to explore Field Trip Health's net income history and peer comparisons.

Field Trip Health's net income decreased from $-33M to $-48M — a 47.1% year-over-year decrease (period ending June 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Field Trip Health's net income of $-48M is lower than the Healthcare sector average of $16B. That is roughly 100.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Field Trip Health reported $-48M in net income as of June 2022. That compares with $-33M in the prior-year period — down 47.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $-48M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $16B. From there, open related valuation or income-statement pages for Field Trip Health, and consider following FTRP for alerts when major investors trade the stock.